SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantirs strong Q3 results and raised outlook, driven by rapid commercial AI growth, are drawing attention, but the shares have weakened despite the beat. Bulls point to accelerating adoption and profitability, while bears argue that expectations and valuation are too high amid pressure on AI stocks.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples earnings beat was overshadowed by its weaker holiday-quarter margin outlook, with traders focused on rising memory costs and softer growth expectations; some also cited misses in China, iPad and wearables. The reaction is sharply divided between bearish concerns about margins and valuation and bullish calls that the selloff overreacts to otherwise strong iPhone results.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is drawing attention amid a choppy market selloff, with traders focused on weakness in tech and AI stocks over spending and debt concerns, alongside uncertainty around the midterm elections and U.S.-Iran tensions. The community is split between expecting further downside and looking for a bounce, with peace-deal speculation and election outcomes seen as potential swing factors.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracles planned stock and bond financing for its AI and data-center buildout is the main focus, with traders citing dilution, debt, and uncertainty over returns on heavy AI spending. Others say the funding plan was already disclosed and view the selloff as an overreaction or buying opportunity, while broader tech weakness added pressure.

Compass Pathways Plc is a biotechnology company, which provides mental health care services. It focuses on improving the lives of those who are suffering with mental health challenges and who are not helped by current treatments. The company was founded by Goldsmith George Jay and Malievskaia Ekaterina in 2016 and is headquartered in London, the United Kingdom.

Compass Pathways Plc - ADR

COMPASS Pathways

CMPS is selling off amid reports that nonprofit Usona has submitted an FDA application for psilocybin in major depressive disorder, raising concerns about competition, pricing and Compass losing a potential first-mover advantage. Traders disagree over how much the news threatens COMP360s treatment-resistant depression market, and some question whether Usonas filing is confirmed; attention is also on Compasss NDA timeline and expected management updates.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Midterm-election uncertainty dominates discussion, with traders debating whether Republican gains could lift DJT or a Democratic wave could pressure it. Bearish posters also question the companys fundamentals and characterize its moves as speculative, while some bulls point to election-related upside.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is drawing attention after a sharp semiconductor-led selloff ahead of its quarterly report, with traders focused on forward guidance and AI/data-center demand amid concerns triggered by Intels outlook and broader tech valuation worries. Many fear even strong results could be sold off, while others see the pullback as overdone and expect a rebound.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

RDDT is drawing attention after a sharp post-earnings selloff, as traders focus on weaker user-growth expectations, declining Google search referrals amid AI-powered search, and Reddits plans to push more visitors to log in. Bearish traders see these as threats to traffic and growth, while dip buyers argue that strong revenue growth and profitability leave the business fundamentally attractive.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

Discussion centers on Fresenius data reporting no significant difference in bloodstream-infection outcomes between DefenCath and ClearGuard, fueling concern that the lower-cost alternative could limit DefenCath adoption and pricing. Some traders argue the retrospective comparison does not establish equivalence and point to DefenCaths other clinical evidence; reimbursement and Medicare Advantage access remain key uncertainties.

Zcash (ZEC) is a cryptocurrency . Users are able to generate ZEC through the process of mining. Zcash has a current supply of 16,946,883.4155448. The last known price of Zcash is 1,152.25968615 USD and is down -6.04 over the last 24 hours. It is currently trading on 668 active market(s) with $1,018,436,174.86 traded over the last 24 hours. More information can be found at https://z.cash/.

Zcash

Zcash is drawing attention after a sharp pullback from its recent rally, with traders debating whether broader crypto weakness and fears surrounding a Binance hack are weighing on the price; some argue Zcash is unaffected and see the dip as a buying opportunity. Traders are also watching the upcoming NU7 network upgrade as a potential catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SLS:
Stergiou’s Masterclass: Engineering a Massive Short Squeeze
The game is rigged, but Stergiou is playing it better. This is a masterclass in forcing a Big Pharma decision.
1. The Boomer Engine: Why Fox &amp; Friends? It’s for the pensions. Targeting early-rising Boomers with deep pockets creates a support level no short-seller can break.
2. The Big Pharma Trap: J&amp;J/Merck won&#39;t pay premiums for distressed assets. Stergiou is forcing their hand, making $SLS too vital to ignore.
3. The Limbo: We’re in &quot;Limbo&quot;—the Twilight Zone between the 80th milestone and Topline Data. Shorts are panicking; this is the perfect setup. If long-term holders stand firm, the shorts get trapped.
4. The Signal: No leaks needed. A confident “Results look excellent” on TV is the spark.
We aren&#39;t waiting for a buyout—we’re manufacturing the conditions that make a bidding war inevitable. $SLS is being built for a takeover. The game has begun. 🚀💵

Bennyterner

Bret

iiro the man

Anthony

LordKhaan

Dan flint

Wayne

Jeff Freedman

Stone Cold Steve Austin

john

Gray Wolf

상후니

50BorBust

Gfywoody

Ehrenhardt

Bconsls007

Chris C

KimJongTinyDong

NorvaK

Anthony Sassin

Big Bull Ben

Persephonia

Wei Bull

Daniel Duong

Allan Kristensen

John-Mark

James

Danny

$SLS Did Yahoo Finance just use my DD as their own reporting? 🧐
I posted my analysis on $SLS yesterday. This morning, Yahoo Finance released an article using my exact phrases—word for word.
Look at the comparison below:
🟡 B: &quot;Masterclass in forcing a Big Pharma decision&quot;
🟣 Y: &quot;...a &#39;masterclass in forcing a Big Pharma decision&#39;&quot;
🟡 B: &quot;Manufacturing the conditions for a bidding war&quot;
🟣 Y: &quot;...manufacturing the conditions that make a bidding war inevitable&quot;
🟡 B: &quot;We aren&#39;t waiting for a buyout—we&#39;re manufacturing the conditions&quot;
🟣 Y: &quot;We aren&#39;t waiting for a buyout—we&#39;re manufacturing the conditions&quot;
Should I sue for copyright, or just take it as an ultimate compliment? You decide.
#SLS #Biotech #DD #StockMarket #MarketAnalysis

StockTwits for iOS

SELLAS Life Sciences Group Inc

:
Stergiou’s Masterclass: Engineering a Massive Short Squeeze
The game is rigged, but Stergiou is playing it better. This is a masterclass in forcing a Big Pharma decision.
1. The Boomer Engine: Why Fox & Friends? It’s for the pensions. Targeting early-rising Boomers with deep pockets creates a support level no short-seller can break.
2. The Big Pharma Trap: J&J/Merck won't pay premiums for distressed assets. Stergiou is forcing their hand, making 

 too vital to ignore.
3. The Limbo: We’re in "Limbo"—the Twilight Zone between the 80th milestone and Topline Data. Shorts are panicking; this is the perfect setup. If long-term holders stand firm, the shorts get trapped.
4. The Signal: No leaks needed. A confident “Results look excellent” on TV is the spark.
We aren't waiting for a buyout—we’re manufacturing the conditions that make a bidding war inevitable. 

 is being built for a takeover. The game has begun. 🚀💵

StockTwits For Android 

Adam Roberts

@BENNYST where do you see this going $30+ possible this year?

 where do you see this going $30+ possible this year?

Mihalis

@MihalisB86 Honestly, $30 is just the beginning if the conditions I outlined keep playing out. We’re looking at a structural squeeze here, not just a standard move. The catalysts in place could take this way beyond that number. I’m not playing for crumbs; I’m playing for the thesis to fully materialize.

 Honestly, $30 is just the beginning if the conditions I outlined keep playing out. We’re looking at a structural squeeze here, not just a standard move. The catalysts in place could take this way beyond that number. I’m not playing for crumbs; I’m playing for the thesis to fully materialize.

@BENNYST Does anyone know when the fox&amp;friends broadcast is on TV? Very curious. Thanks!

 Does anyone know when the fox&friends broadcast is on TV? Very curious. Thanks!

YN Automotive

@YNStocks18 , based on the current market dynamics and the strategic setup we&#39;ve been tracking, the window we are targeting is tomorrow. As with all high-stakes moves in this sector, timing is everything—stay tuned.

 , based on the current market dynamics and the strategic setup we've been tracking, the window we are targeting is tomorrow. As with all high-stakes moves in this sector, timing is everything—stay tuned.